MA
CRL icon

MJP Associates’s Charles River Laboratories CRL Stock Holding History

MJP Associates’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,263
Closed -$233K – 232
2024
Q4 		$233K Sell
1,263
-3,334
-73% -$642K 0.04% 204
2024
Q3 		$905K Sell
4,597
-1,439
-24% -$299K 0.17% 70
2024
Q2 		$1.25M Buy
6,036
+1,300
+27% +$295K 0.26% 44
2024
Q1 		$1.28M Buy
4,736
+361
+8% +$86.2K 0.28% 40
2023
Q4 		$1.03M Buy
4,375
+364
+9% +$71.6K 0.28% 38
2023
Q3 		$786K Buy
+4,011
New +$823K 0.23% 41

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MJP Associates's CRL Position: Q1 2025 in Review

MJP Associates sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 1,263 shares — an estimated $233K sold.

MJP Associates first reported a position in CRL in Q3 2023 and held it in 6 quarters. The position peaked at $1.28M in Q1 2024. 560 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • MJP Associates reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • MJP Associates sold 1,263 Charles River Laboratories shares in Q1 2025, an estimated $233K.
  • MJP Associates first reported a position in Charles River Laboratories in Q3 2023 and held it in 6 quarters.
  • MJP Associates's Charles River Laboratories position peaked at $1.28M in Q1 2024.
  • 560 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on MJP Associates's 13F filing for Q1 2025, filed 30 Apr 2025.